Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

It’s the Era of Outcomes at ERA 2023

The Medscape team has bid farewell to the beautiful city of Milano, Italy and our European nephrology colleagues. The team was thrilled to meet up with so many ground-breaking clinicians,...

Medscape Education

- PMLiVE

The goldfish principle: making sense of persuasive communication

By Susan Walkley

- PMLiVE

Using knowledge graphs to discover powerful new insights

Looking at how multidimensional knowledge graphs work and their potential within the life sciences industry

- PMLiVE

Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata

Almost 20% of patients with the autoimmune disease are diagnosed before the age of 18

- PMLiVE

Sanofi and Sobi’s haemophilia A treatment shows effective bleed protection in children

Current factor VIII therapies usually require patients to receive treatment multiple times a week

- PMLiVE

International Respiratory Coalition urges policymakers to help lift disease burden

The societal and economic cost of respiratory disease in Europe is reportedly over €600bn

- PMLiVE

Swordfish Advertising appoints Sarah Rush as new CEO

Rush has been serving as the agency’s client services director since 2019

- PMLiVE

The patient voice

We believe that listening to people's lived experiences are vital components of our work.

Havas Life London

- PMLiVE

Strategies for engaging patients in the digital age

By Laura Meade

- PMLiVE

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the third year running

We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.

Oxford PharmaGenesis

- PMLiVE

FDA grants accelerated approval to Sarepta’s Duchenne muscular dystrophy gene therapy

The disease occurs in up to one in every 5,000 newborn males worldwide

- PMLiVE

World Health Organization publishes research agenda for antimicrobial resistance

AMR has been declared by WHO as one of the top ten threats to global public health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links